Total Payments
$2,793
2024 Payments
$291.55
Companies
13
Transactions
165
Medicare Patients
549
Medicare Billing
$70,474
Payment Breakdown by Category
Food & Beverage$2,781 (99.6%)
Education$12.50 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,781 | 163 | 99.6% |
| Education | $12.50 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $725.98 | 42 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $671.26 | 53 | $0 (2023) |
| PFIZER INC. | $409.66 | 32 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $273.49 | 15 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $179.47 | 10 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $130.92 | 2 | $0 (2017) |
| Relypsa, Inc. | $121.87 | 1 | $0 (2017) |
| Inspire Medical Systems, Inc. | $96.64 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $90.24 | 4 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $37.11 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $291.55 | 11 | Novartis Pharmaceuticals Corporation ($105.31) |
| 2023 | $295.85 | 15 | Novartis Pharmaceuticals Corporation ($142.35) |
| 2022 | $482.57 | 28 | Novartis Pharmaceuticals Corporation ($164.03) |
| 2021 | $722.43 | 46 | Novartis Pharmaceuticals Corporation ($314.29) |
| 2020 | $44.95 | 3 | E.R. Squibb & Sons, L.L.C. ($44.95) |
| 2019 | $55.26 | 4 | E.R. Squibb & Sons, L.L.C. ($41.00) |
| 2018 | $370.58 | 30 | E.R. Squibb & Sons, L.L.C. ($232.52) |
| 2017 | $529.98 | 28 | SANOFI-AVENTIS U.S. LLC ($130.92) |
All Payment Transactions
165 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $96.64 | General |
| Category: NEUROLOGY | ||||||
| 08/22/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: Infectious Diseases | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/16/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Infectious Diseases | ||||||
| 05/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/27/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/29/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/22/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/15/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/24/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/21/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/07/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $6.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/06/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.30 | General |
| Category: Cardiovascular | ||||||
| 05/18/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/10/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.00 | General |
| Category: Cardiovascular | ||||||
| 05/08/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/27/2023 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Infectious Diseases | ||||||
| 03/15/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $17.41 | General |
| 03/10/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $32.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 108 | 176 | $31,597 | $16,573 |
| 2022 | 3 | 105 | 202 | $33,115 | $16,290 |
| 2021 | 4 | 87 | 159 | $23,430 | $12,609 |
| 2020 | 9 | 249 | 317 | $107,908 | $25,002 |
Total Patients
549
Total Services
854
Medicare Billing
$70,474
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 52 | 120 | $19,935 | $10,934 | 54.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 34 | 34 | $5,522 | $2,911 | 52.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 22 | $6,140 | $2,728 | 44.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 59 | 154 | $23,163 | $11,715 | 50.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 34 | 36 | $5,364 | $2,941 | 54.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $4,588 | $1,635 | 35.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 18 | 60 | $8,820 | $4,855 | 55.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 25 | 55 | $5,940 | $3,095 | 52.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 30 | 30 | $4,470 | $2,464 | 55.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 14 | $4,200 | $2,195 | 52.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 54 | 115 | $13,244 | $6,525 | 49.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 39 | 40 | $24,830 | $5,841 | 23.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 29 | 29 | $7,459 | $2,415 | 32.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 22 | 27 | $17,619 | $2,186 | 12.4% |
| 99218 | Hospital observation care, typically 30 minutes | Facility | 2020 | 26 | 26 | $11,310 | $2,124 | 18.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 23 | 23 | $8,175 | $1,736 | 21.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 25 | 26 | $9,466 | $1,533 | 16.2% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 11 | 11 | $7,303 | $1,481 | 20.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 20 | 20 | $8,502 | $1,162 | 13.7% |
About Dr. Remi Trien, M.D
Dr. Remi Trien, M.D is a Emergency Medicine healthcare provider based in El Paso, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2011. The National Provider Identifier (NPI) number assigned to this provider is 1639465057.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Remi Trien, M.D has received a total of $2,793 in payments from pharmaceutical and medical device companies, with $291.55 received in 2024. These payments were reported across 165 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,781).
As a Medicare-enrolled provider, Trien has provided services to 549 Medicare beneficiaries, totaling 854 services with total Medicare billing of $70,474. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Internal Medicine
- Location El Paso, TX
- Active Since 06/23/2011
- Last Updated 01/31/2019
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639465057
Products in Payments
- ELIQUIS (Drug) $915.46
- ENTRESTO (Drug) $707.11
- XARELTO (Drug) $273.49
- BRILINTA (Drug) $139.90
- Veltassa (Drug) $121.87
- CHANTIX (Drug) $119.99
- PRALUENT (Drug) $112.97
- INSPIRE (Device) $96.64
- Cresemba (Drug) $75.30
- LOKELMA (Drug) $39.57
- XIFAXAN (Drug) $37.11
- DALVANCE (Drug) $21.05
- Soliris (Drug) $19.55
- LEQVIO (Drug) $18.87
- HYPERLIPIDEMIA - DISEASE (Drug) $17.95
- CLEVIPREX (Drug) $15.93
- Lexiscan (Drug) $14.94
- PREVNAR - 13 (Biological) $14.10
- ELELYSO (Drug) $0.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in El Paso
Dr. Armando Molina, Md, MD
Emergency Medicine — Payments: $254,755
Emergency Medicine $254,755
Dr. Douglas Cromack, M.d, M.D
Emergency Medicine — Payments: $90,307
Emergency Medicine $90,307
Dr. Sergio Ibarra, Md, MD
Emergency Medicine — Payments: $86,419
Emergency Medicine $86,419
Edward Michelson, Md, MD
Emergency Medicine — Payments: $62,673
Emergency Medicine $62,673
Dr. Oluwamayowa Familua, M.d., Mrcs., Fics, M.D., MRCS., FICS
Emergency Medicine — Payments: $29,957
Emergency Medicine $29,957
Dr. Azalia Martinez, M.d., Faap, M.D., FAAP
Emergency Medicine — Payments: $5,161
Emergency Medicine $5,161